Jade Biosciences JBIO
NASDAQ JBIO
$13.77 -0.28 (-1.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Accumulated Depreciation (2020 - 2021)

Updated

Jade Biosciences (JBIO) posted Accumulated Depreciation of $5,000 for Q2 2021.

Analysis

Jade Biosciences (JBIO) Accumulated Depreciation (2020 - 2021) Analysis & Trends

At the end of FY2020, Jade Biosciences' Accumulated Depreciation came in at $1,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Jade Biosciences 892.96 Mn 892.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 5,000.00
Dec 31, 2020 1,000.00
API Access

Jade Biosciences Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=JBIO&period=max&api_key=YOUR_API_KEY